These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35336054)

  • 21. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
    Du X; Gao N; Song X
    Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system.
    Fong Yen W; Basri M; Ahmad M; Ismail M
    ScientificWorldJournal; 2015; 2015():495271. PubMed ID: 25853145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers.
    Krishnaiah YS; Raju V; Shiva Kumar M; Rama B; Raghumurthy V; Ramana Murthy KV
    Pharm Dev Technol; 2008; 13(3):177-85. PubMed ID: 18484486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and in-vivo evaluation of ondansetron gels for transdermal delivery.
    Patel DR; Joshi A; Patel HH; Stagni G
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1030-6. PubMed ID: 24919508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
    Datta D; Panchal DS; Venuganti VVK
    Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limonene enhances the in vitro and in vivo permeation of trimetazidine across a membrane-controlled transdermal therapeutic system.
    Krishnaiah YS; Al-Saidan SM
    Curr Drug Deliv; 2008 Jan; 5(1):70-6. PubMed ID: 18220554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a reservoir-type transdermal delivery system containing eucalyptus oil for tetramethylpyrazine.
    Shen T; Xu H; Weng W; Zhang J
    Drug Deliv; 2013; 20(1):19-24. PubMed ID: 23311649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride.
    Prasanthi D; Lakshmi PK
    ISRN Pharm; 2012; 2012():965280. PubMed ID: 23316394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
    Funke AP; Günther C; Müller RH; Lipp R
    J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
    Mahmood S; Taher M; Mandal UK
    Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.